Auxilius

Financial Software · New York, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

New York City, New York, United States

Phone Number

(201) 380-4453

Revenue

$9.5 Million

Industry

Financial Software Software Business Intelligence (BI) Software
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
4
2
3
2
1

About Auxilius

Auxilius is a New York-based clinical trial financial management software company founded in 2020 that serves the biopharmaceutical industry. The company provides a specialized platform designed to automate and streamline research and development financial operations for biotech and pharmaceutical companies conducting clinical trials. Auxilius integrates real-time clinical data, invoices, vendor estimates, and team input to automate expense accruals, budgeting, forecasting, and financial planning processes that traditionally rely on manual spreadsheet management. The platform addresses the complexity of managing clinical trial finances by consolidating data from multiple sources into a single workflow, enabling finance, accounting, and clinical operations teams to improve forecast accuracy, control trial costs, and manage financial risk more effectively. Auxilius features investigator spend intelligence that maps patient visits and procedures to site contracts, site payment reconciliatRead more
Popular SearchesAuxiliusSIC Code 73,737NAICS Code 51,513Show more

Auxilius Org Chart

Adam Weisman, Chief Executive Officer & Co-Founder at Auxilius
United States flag for contact location.

Chief Executive Officer & Co-Founder

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
EG
United States flag for contact location.

President & Chief Operating Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Auxilius your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Software companies

Low Activity

High Activity

Activity Insights

Auxilius is experiencing very low activity levels compared to other companies in the Software sector.

What does this means?

Auxilius is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Auxilius.

Auxilius financials insights

Gather financial insights about Auxilius, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2022

Series A

$10M

2024

Other Financing Round

$10M

See All Auxilius's Financials Insights

Most Recent Scoops

Funding
Funding
Open Position
Open Position
New Hire
Executive Move
Funding
See more scoops

Auxilius News & Media

Read more news

Top Financial Software Companies

Frequently Asked Questions Regarding Auxilius

What is Auxilius's official website?
Auxilius's official website is www.auxilius.co
What is Auxilius's Revenue?
Auxilius's revenue is $9.5 Million
What is Auxilius's SIC code?
Auxilius's SIC: 73,737
What is Auxilius's NAICS code?
Auxilius's NAICS: 51,513
How many employees does Auxilius have?
Auxilius has 11-50 employees
What industry does Auxilius belong to?
Auxilius is in the industry of: Financial Software, Software, Business Intelligence (BI) Software
How do I contact Auxilius?
Auxilius contact info: Phone number: (201) 380-4453 Website: www.auxilius.co
What does Auxilius do?

Auxilius is a New York-based clinical trial financial management software company founded in 2020 that serves the biopharmaceutical industry. The company provides a specialized platform designed to automate and streamline research and development financial operations for biotech and pharmaceutical companies conducting clinical trials. Auxilius inte... grates real-time clinical data, invoices, vendor estimates, and team input to automate expense accruals, budgeting, forecasting, and financial planning processes that traditionally rely on manual spreadsheet management. The platform addresses the complexity of managing clinical trial finances by consolidating data from multiple sources into a single workflow, enabling finance, accounting, and clinical operations teams to improve forecast accuracy, control trial costs, and manage financial risk more effectively. Auxilius features investigator spend intelligence that maps patient visits and procedures to site contracts, site payment reconciliation capabilities that validate transactions against clinical systems, and built-in controls designed to support audit readiness and strengthen compliance with Sarbanes-Oxley requirements. The platform integrates with existing clinical trial management systems, electronic data capture tools, and enterprise resource planning systems without replacing them, generating journal entry upload files and exportable forecasts for incorporation into broader budgeting processes. Auxilius pairs its purpose-built software with a dedicated operations team that includes certified public accountants, finance professionals, and former auditors who provide ongoing customer support. The company is venture-backed by investors including Renegade Partners, SignalFire, Bain Capital Ventures, and XYZ Venture Capital, and serves over 65 biopharmaceutical companies across private and public markets.Read More

Who invested in Auxilius?
Auxilius has 4 investors including SignalFire, Bain Capital Ventures, Renegade Partners and XYZ Venture Capital.
Is Auxilius a public company?
Auxilius is private company therefore does not currently have an official ticker symbol
See more information about Auxilius

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.